INVITRO CHARACTERIZATION OF SALMONELLA-TYPHI MUTANT STRAINS FOR LIVE ORAL VACCINES

被引:11
作者
DRAGUNSKY, EM
RIVERA, E
HOCHSTEIN, HD
LEVENBOOK, IS
机构
[1] Division of Product Quality Control, Office of Biological Product Review, Center for Biologics Evaluation and Research, Bethesda, MD 20892
关键词
macrophage U937 line; Salmonella typhi; virulence test in vitro;
D O I
10.1016/0264-410X(90)90056-R
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several Salmonella typhi attenuated mutant strains, suggested as candidates for live oral vaccine, were examined for their characteristics in vitro in comparison with parental strains Ty2 and CDC10-80. Three methods were used: interaction of bacteria with the human monocyte-macrophage U937 cell line evaluated by microscopic examination, bacterial growth in the cell culture medium estimated by absorbance and bacterial resistance to human plasma assessed by the viable count technique. The most informative data were obtained in the test with U937 cells. Ty2 penetrated almost 100% of the cells, multiplied rapidly and caused death of the cells. CDC10-80 infected about 30% of the cells, multiplied slightly and did not kill the cells. The Ty2 mutant galE via EX462 behaved like CDC10-80. Bacteria of the galED Ty21a, Vi + Ty21a, 541Ty and 543Ty, found in only 3-4% of the cells, did not multiply within the cells and decreased in number with time. These findings correlate with the reported virulence of these strains for humans. With the second method, the rate of bacterial growth in cell culture medium did not differentiate Ty2, CDC10-80 and EX462. They grew at the same rate and faster than the remaining mutants. The plasma resistance test did not discriminate between EX462 and other mutants. These tests did not reveal any difference between Vi + Ty21a and Vi -Ty21a. © 1990.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 18 条
[1]   CONTROLLED FIELD TRIAL IN BRITISH GUIANA SCHOOL CHILDREN OF HEAT-KILLED-PHENOLIZED + ACETONE-KILLED LYOPHILIZED TYPHOID VACCINES [J].
ASHCROFT, MT ;
RITCHIE, JM ;
NICHOLSON, CC .
AMERICAN JOURNAL OF HYGIENE, 1964, 79 (02) :196-+
[2]   SALMONELLA-TYPHI VACCINE STRAIN INVITRO - LOW INFECTIVITY IN HUMAN CELL-LINE U937 [J].
DRAGUNSKY, EM ;
WOODEN, CR ;
VARGO, SA ;
LEVENBOOK, IS .
JOURNAL OF BIOLOGICAL STANDARDIZATION, 1989, 17 (04) :353-360
[3]   CONSTRUCTION OF DELTA-AROA HIS DELTA-PUR STRAINS OF SALMONELLA-TYPHI [J].
EDWARDS, MF ;
STOCKER, BAD .
JOURNAL OF BACTERIOLOGY, 1988, 170 (09) :3991-3995
[4]  
FINLAY BB, 1989, SCIENCE, V6243, P9413
[6]   ISOLATION AND CHARACTERIZATION OF GAL-E MUTANT TY 21A OF SALMONELLA-TYPHI - CANDIDATE STRAIN FOR A LIVE, ORAL TYPHOID VACCINE [J].
GERMANIER, R ;
FURER, E .
JOURNAL OF INFECTIOUS DISEASES, 1975, 131 (05) :553-558
[7]   EVALUATION OF A UDP-GLUCOSE-4-EPIMERASELESS MUTANT OF SALMONELLA-TYPHI AS A LIVE ORAL VACCINE [J].
GILMAN, RH ;
HORNICK, RB ;
WOODWARD, WE ;
DUPONT, HL ;
SNYDER, MJ ;
LEVINE, MM ;
LIBONATI, JP .
JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (06) :717-723
[8]   A GALE-VIA (VI-ANTIGEN-NEGATIVE) MUTANT OF SALMONELLA-TYPHI TY2 RETAINS VIRULENCE IN HUMANS [J].
HONE, DM ;
ATTRIDGE, SR ;
FORREST, B ;
MORONA, R ;
DANIELS, D ;
LABROOY, JT ;
BARTHOLOMEUSZ, RCA ;
SHEARMAN, DJC ;
HACKETT, J .
INFECTION AND IMMUNITY, 1988, 56 (05) :1326-1333
[9]   SAFETY, INFECTIVITY, IMMUNOGENICITY, AND INVIVO STABILITY OF 2 ATTENUATED AUXOTROPHIC MUTANT STRAINS OF SALMONELLA-TYPHI, 541TY AND 543TY, AS LIVE ORAL VACCINES IN HUMANS [J].
LEVINE, MM ;
HERRINGTON, D ;
MURPHY, JR ;
MORRIS, JG ;
LOSONSKY, G ;
TALL, B ;
LINDBERG, AA ;
SVENSON, S ;
BAQAR, S ;
EDWARDS, MF ;
STOCKER, B .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :888-902
[10]  
LEVINE MM, 1987, LANCET, V1, P1049